138 related articles for article (PubMed ID: 36333876)
1. HISMD: A Novel Immune Subtyping System for HNSCC.
Yang D; Wu Y; Wan Z; Xu Z; Li W; Yuan P; Shang Q; Peng J; Tao L; Chen Q; Dan H; Xu H
J Dent Res; 2023 Mar; 102(3):270-279. PubMed ID: 36333876
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear phagocyte system-related multi-omics features yield head and neck squamous cell carcinoma subtypes with distinct overall survival, drug, and immunotherapy responses.
Zhang C; Deng J; Li K; Lai G; Liu H; Zhang Y; Xie B; Zhong X
J Cancer Res Clin Oncol; 2024 Jan; 150(2):37. PubMed ID: 38279056
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of immune-related microbiome and prognostic model in head and neck squamous cell carcinoma.
Liu Y; Lin H; Zhong W; Zeng Y; Zhou G; Chen Z; Huang S; Zhang L; Liu X
Clin Oral Investig; 2024 Apr; 28(5):263. PubMed ID: 38642188
[TBL] [Abstract][Full Text] [Related]
4. Subtyping of head and neck squamous cell cancers based on immune signatures.
Song D; Lyu H; Feng Q; Luo J; Li L; Wang X
Int Immunopharmacol; 2021 Oct; 99():108007. PubMed ID: 34332341
[TBL] [Abstract][Full Text] [Related]
5. Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses.
Huang ZD; Liu ZZ; Liu YY; Fu YC; Lin LL; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():791621. PubMed ID: 35003112
[TBL] [Abstract][Full Text] [Related]
6. A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma.
Li W; Huang Q; Peng Y; Pan S; Hu M; Wang P; He Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15923-15938. PubMed ID: 37673824
[TBL] [Abstract][Full Text] [Related]
7. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
9. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
Chen L; Zeng H; Zhang M; Luo Y; Ma X
Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946
[TBL] [Abstract][Full Text] [Related]
10. Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma.
Sun J; Fang G; Zuo Z; Yu X; Xue L; Li C; Li S
Technol Cancer Res Treat; 2021; 20():15330338211045823. PubMed ID: 34657509
[TBL] [Abstract][Full Text] [Related]
11. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
12. Immune signaling-based Cascade Propagation approach re-stratifies HNSCC patients.
Liu K; Chyr J; Zhao W; Zhou X
Methods; 2016 Dec; 111():72-79. PubMed ID: 27339942
[TBL] [Abstract][Full Text] [Related]
13. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
14. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
[TBL] [Abstract][Full Text] [Related]
17. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
Front Immunol; 2022; 13():961695. PubMed ID: 36389709
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
19. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
Front Genet; 2022; 13():1085700. PubMed ID: 36579330
[No Abstract] [Full Text] [Related]
20. Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma.
Peng C; Ye H; Li Z; Duan X; Yang W; Yi Z
J Transl Med; 2023 Jan; 21(1):15. PubMed ID: 36627705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
